85%Confidence
0Views
FDASource
2026-05-26Date
Summary
A sterility assurance failure for BD's PurPrep antiseptic applicators raises concerns about infection risk in clinical settings. This may lead to product recalls, reputational damage for Becton Dickinson, and potential market share loss to competitors.
Actionable: Monitor Becton Dickinson's stock for potential short-term volatility and assess alternative antiseptic suppliers.
AI Confidence: 85%
Data Points
firmCareFusion 213, LLC
classificationClass II
statusOngoing
distributionNationwide in the USA
productBD PurPrep, Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alcohol 72.5% w/w Sterile Solution, 0.36 fl. oz. (10.5 mL) x 25 applicato
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now